Modulo
Curated by SignalAI-powered drug development platform to treat neurological conditions
Overview
AI-powered drug development platform to treat neurological conditions. The company's Neuroimmune Platform leverages emerging technologies and cutting-edge neuroscience to develop therapeutic drugs that effectively target the neuroimmune system.
Key facts
- Founded
- 2021
- Headquarters
- San Diego, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Contact
- Primary office
- Sign up to view
- Sign up to view